We are
thrilled to announce the creation of Remedi, a groundbreaking union between
industry pioneers Regenera Activa and Rigenera HBW. This strategic merger marks
a significant milestone in the scope of regenerative medicine, meant to
redefine standards and drive transformative advancements in healthcare.
The
official announcement took place at the IMCAS World Congress in Paris on
February 1, 2024. Alexandre Andreu, CEO of Regenera Activa, and Antonio
Graziano, CEO of HBW, delivered compelling speeches about the shared vision and
unparalleled potential of this collaboration.
At Remedi,
our mission is clear: to propel scientific innovation forward with unwavering
dedication and collaborative spirit. By harnessing the collective expertise,
resources, and insights of both entities, we are poised to unlock new frontiers
in regenerative medicine.
This
strategic alliance signifies more than just a merger of two entities; it
represents a fusion of passion, expertise, and commitment to excellence.
Together, we embark on a journey to revolutionize patient care, driving
positive outcomes and shaping the future of healthcare.
Welcome to
Remedi - where innovation meets purpose, and the future of regenerative
medicine begins.
RELATED NEWS
